TNF and breast neoplasm: If generalized through investigation in other suitable breast tumor systems, such mechanisms imply that in breast cancer patients whose tumors contain high levels of the inflammatory cytokine TNFα and whose cancer cells generally do not carry mutations in Ras, TNFα may activate WT-Ras towards a pro-cancerous phenotype that leads to devastating tumor-promoting outcomes.